Use of real-world evidence (RWE) in support of regulatory filings continues to be a key focus area among life sciences companies. As the field learns from regulator feedback about how RWE can meaningfully contribute to submissions, we begin to get a clearer picture of near-term opportunities for regulatory RWE. Hear from life science leaders about how their organizations have successfully applied RWE in recent regulatory submissions, as well as Flatiron’s evolving perspective on the use of RWE for regulatory use.
Beyond synthetic controls: Near term opportunities for regulatory RWDC T2023-02-12T05:19:12-05:00
Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.
Join experts from PHAR, Novartis, and Bausch Health for a discussion around the Delphi panels and how the results are used.
Experts will present opportunities for using agile platforms and fit-for-purpose engagement models that can drive an iterative approach to obtaining payer insights and developing impactful evidence generation strategies.